Obsidio Conformable Embolic Recall Issued After Reports of Deaths, Serious Injuries
Boston Scientific reports that seven patients have been injured and two have died due to restricted blood flow caused by Obsidio Embolic side effects.
Boston Scientific reports that seven patients have been injured and two have died due to restricted blood flow caused by Obsidio Embolic side effects.
Lawsuit over the Angiodynamics port catheter raises allegations similar to those found in hundreds of Bard PowerPort lawsuits, indicating that device was defectively designed and increases the risk of infections, other injuries.
At least 10 patient injuries and one death have been reported in connection to the Arrow QuickFlash catherization kit recall.
Judge compared Bard PowerPort lawsuits to IVC filter litigation, where the majority of cases were filed more than 18 months after the claims were consolidated into a MDL
Of the 25 Bard chemo port devices on the market, at least 15 have been identified in lawsuits filed over failures, infections and other complications among individuals who received the implantable port catheter.
The outcome of the early bellwether test trials could impact the average Bard Power Port lawsuit settlement amounts the manufacturer may need to pay to avoid hundreds of claims being remanded for individual trials.
Judge has approved a new streamlined process for plaintiffs to file Bard Power Port lawsuits directly in the U.S. District Court for the District of Arizona, where the federal litigation is centralized.
The presiding judge has determined that six Bard PowerPort lawsuits will ultimately be chosen for the first bellwether trials.
Plaintiffs and defendants suggest an initial pool of 48 Bard PowerPort lawsuits be selected as part of an initial discovery pool, which will be prepared for a series of early trial dates in the federal Multidistrict Litigation (MDL)
The FDA warns that the recalled syringes could cause infections, blood loss, increased blood clot risks, embolism and death.